SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Unquoted Biotechs
An SI Board Since July 2001
Posts SubjectMarks Bans
253 23 0
Emcee:  nigel bates Type:  Unmoderated
Introduction Compact
Place to post interesting stuff for future reference.
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
253WATERTOWN, Mass., Aug. 8, 2018 /PRNewswire/ -- SQZ Biotechnologies (SQZ), a cellnigel bates-11/1/2018
252Aptinyx just did a 70 million B round financing. It was spun out from Naurex/Altuck-12/18/2017
251CAMBRIDGE, Mass., September 14, 2017 — Moderna Therapeutics, a clinical stage binigel bates-9/14/2017
250Seems worthy of note, with 5 compounds in PIII, and raising a billion plus... Bnigel bates-8/9/2017
249CAMBRIDGE, Mass., January 13, 2015 — Moderna Therapeutics today announced a licenigel bates-1/13/2015
248(Oxford, UK and Philadelphia, PA, 2 June 2014). Adaptimmune Limited, a leading bnigel bates-6/2/2014
247(Oxford, UK, 8 January 2014) Immunocore Limited, the Oxford-based biotechnology nigel bates-1/8/2014
246(Oxford, UK, 9 July 2013) Immunocore Limited, the Oxford-based biotechnology comnigel bates-7/15/2013
245Sounds too good to be true. Looking forward to the phase-1 trial in a couple of DewDiligence_on_SI16/17/2013
244LONDON, June 17 (Reuters) - British scientists have won early financial backing nigel bates-6/17/2013
243Possibly interesting. They have existing collaborations with Pfizer & Amgen.nigel bates-4/23/2013
242Soon to be quoted... Quintiles. The company gets no cash from this IPO, so it pgo-neil-2/15/2013
241This looks a very interesting project (& they subsequently completed a $38m nigel bates-1/21/2013
240AstraZeneca and Ardelyx today announced a worldwide exclusive licensing agreemennigel bates-10/8/2012
239Interesting analysis of VC returns on the biggest private financings in 2007: linigel bates-8/30/2012
2384s3 Bioscience, Inc. Secures $20M in Series A Financing Medford, MA, USA, Martnsaf-3/5/2012
237IP Group plc – Portfolio company Oxford Nanopore to commercialise technology in nigel bates-2/1/2012
236Ensemble Therapeutics. Interesting in that its platform involves macrocyclic drtuck-7/21/2011
235Yes. Correct. I've been tongue-in-cheek suggesting, for several years, thascaram(o)uche-6/8/2010
234From the venture cap funding paragraph near the end, I'm guessing Ergonex maIan@SI-5/12/2010
233ACT BIOTECH Announces FDA Acceptance of IND for ACTB1003, a First-in-Class Anti-scaram(o)uche-1/22/2010
232No longer unquoted... <b>Mondobiotech Holding AG goes public on 26th Augughmm-8/27/2009
231>>than Isotechnika...<< Cruel, mentioning them.nigel bates-6/3/2009
230It will be interesting to see if Concert has better success with duterated compotnsaf-6/3/2009
229But too heavy to last, eh?tnsaf-6/3/2009
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News